Triclofos sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for triclofos sodium and what is the scope of freedom to operate?
Triclofos sodium
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for triclofos sodium
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Clinical Trials: | 1 |
Patent Applications: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | triclofos sodium at DailyMed |
Recent Clinical Trials for triclofos sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rabin Medical Center | Phase 4 |
US Patents and Regulatory Information for triclofos sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TRICLOS | triclofos sodium | SOLUTION;ORAL | 016830-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | TRICLOS | triclofos sodium | TABLET;ORAL | 016809-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |